Kronox Lab Sciences Limited
Book Built Issue IPO · NSE, BSE
- Price band
- ₹129 - ₹136
- Lot size
- 110 shares
- Issue amount
- ₹130.15 cr
- Total subscription
- 117.25×
- Opens
- 3 Jun 2024
- Closes
- 5 Jun 2024
- Allotment
- 6 Jun 2024
- Listing
- 10 Jun 2024
Offer at a glance
Issue overview
- Issue size
- 95,70,000 shares
- Face value
- ₹10 Per Equity Share
- Minimum investment
- ₹14,190
- Fresh issue
- ₹0 cr
- Offer for sale
- ₹130.15 cr
- Registrar
- Kfin Technologies Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,960
- Issue type
- Book Built Issue IPO
- Shares before issue
- 3,71,04,000
- Shares after issue
- 3,71,04,000
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 110 | ₹14,960 |
| sHNI | 14 | 1,540 | ₹2,09,440 |
| bHNI | 67 | 7,370 | ₹10,02,320 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| HNIs(10L +) | 621 | 40,181 |
| HNIs (2-10L) | 311 | 78,159 |
| RETAIL | 30,450 | 14,11,824 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 26.03 | 2,317.57 |
| RETAIL | 45.55 | 2,470.31 |
| HNIs 2+ | 6.51 | 1,699.89 |
| HNIs 10+ | 13.02 | 4,194.33 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Dec-23 | Mar-23 | Mar-22 |
|---|---|---|---|
| EPS | 4.17 | 4.3 | 3.49 |
| ROE | 25.66 | 37.19 | 33.77 |
| ROCE | 33.15 | 33.5 | 49.86 |
| RONW | 25.66 | 37.19 | 33.77 |
| PRE IPO(PE) | 8.37 | 0 | 0 |
| POST IPO(PE) | 30.37 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Kronox Lab Sciences Limited, founded in 2008, is a leading manufacturer of high-purity speciality chemicals used in various industries like pharmaceuticals, biotech, agrochemicals, personal care, and animal health. The company offers 185+ products such as phosphate, sulphate, chloride, and EDTA derivatives, serving customers in India and over 20 countries including the USA, Australia, UK, and China. Kronox operates three manufacturing units in Vadodara, Gujarat with a total capacity of 7,242 TPA. Their facilities follow strict quality standards with certifications like ISO, FSSC, Kosher, Halal, GMP, and GLP. The company focuses heavily on research and development, working on 122 new products and serving 592+ customers in the last three years, with many returning for repeat orders.
Strengths
- Wide Product Range and Versatile Uses: Kronox Lab Sciences Limited provides 185+ high-purity speciality fine chemicals used in pharmaceuticals, nutraceuticals, biotech, agrochemicals, personal care, metal refineries, and animal health industries.
- Strong Customer Bonds: The company serves 592+ customers , out of which 141 customers place repeat orders , showing customer trust and satisfaction .
- Tough Market Entry & Exit: Strict product quality standards and lengthy customer approval processes make it difficult for new competitors to enter or exit the market , helping Kronox maintain a strong market position .
Risk factors
- Strict Industry Standards Compliance: If the company doesn't follow domestic and international industry standards, customers may reject the products, which could harm the company's reputation.
- Dependence on Third-Party Logistics: The company relies on outside logistics providers for transportation. This could lead to delays, higher costs, theft, accidents, or product loss during delivery, affecting business operations and profits.
- High P/E Ratio: The company’s stock is priced much higher than the industry average, which could be risky if the market shifts or if the company fails to meet its growth expectations.
Promoters
Jogindersingh Jaswal
Ketan Ramani
Pritesh Ramani
Registrar & documents
Lead manager
Pantomath Capital Advisor Private Limited
Registrar & contacts
Kfin Technologies Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
Block No. 353, Village Ekalbara, Padra, Vadodara-391440
+91 26 6224 4077/88
[email protected]Company website ↗Frequently Asked Questions
What is Kronox Lab Sciences IPO GMP today?
As of today, Kronox Lab Sciences IPO Grey Market Premium (GMP) is reported at +₹28 per share. Based on the upper price band of ₹136, the estimated listing price is ₹164 (+20.6% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.
What is the lot size and minimum investment for Kronox Lab Sciences IPO?
The minimum bid lot size for Kronox Lab Sciences IPO is 110 shares. At the cut-off price of ₹136 per share, retail investors need a minimum application amount of ₹14,960 per lot. Retail applicants can apply for a maximum of 13 lots (up to ₹2,00,000).
When will Kronox Lab Sciences IPO allotment status be announced?
The allotment status for Kronox Lab Sciences IPO is scheduled to be finalized on 6 Jun 2024. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Kfin Technologies Limited's official portal or via BSE/NSE allotment portals.
How can I check Kronox Lab Sciences IPO allotment status online by PAN?
To check Kronox Lab Sciences IPO allotment status: 1) Visit the registrar portal (Kfin Technologies Limited) or the BSE IPO allotment page. 2) Select 'Kronox Lab Sciences Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.